雜志介紹

Alimentary Pharmacology & Therapeutics雜志介紹

《Alimentary Pharmacology & Therapeutics》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱消化道藥理學與治療學，本刊主要出版、報道醫(yī)學-PHARMACOLOGY & PHARMACY領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為6.6，最新CiteScore 指數(shù)為15.6。

本刊近期中國學者發(fā)表的論文主要有：

• Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone

  Author: Wang, Jian; Yan, Xiaomin; Zhu, Li; Liu, Jiacheng; Qiu, Yuanwang; Li, Yiguang; Liu, Yilin; Xue, Ruifei; Zhan, Jie; Jiang, Suling; Geng, Yu; Wan, Yawen; Li, Ming; Mao, Minxin; Gao, Dongmei; Yin, Shengxia; Tong, Xin; Xia, Juan; Ding, Weimao; Chen, Yuxin; Li, Jie; Zhu, Chuanwu; Huang, Rui; Wu, Chao

• Sleep duration and daytime napping in relation to incident inflammatory bowel disease: a prospective cohort study

  Author: Yuan, Shuai; Sun, Yuhao; Tan, Xiao; Geng, Jiawei; Sun, Jing; Chen, Xuejie; Yu, Lili; Wang, Jiayi; Zhou, Xuan; Hesketh, Therese; Larsson, Susanna C.; Chen, Jie; Wang, Xiaoyan; Li, Xue; Liu, Zhanju

• TLR8 agonist partially improves IFN-gamma deficiency of NK cells in chronic hepatitis B through the synergy of monocytes

  Author: Ao, Xiulan; Gan, Qiaorong; Huang, Xuan; Bao, Dongpeng; Wu, Xuwei; Lin, Qiuxiang; Lin, Aifang; Ding, Yating; Wang, Lingxia; Chen, Yanping; Huang, Zuxiong

• Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study

  Author: Chen, Jie; Ruan, Xixian; Yuan, Shuai; Deng, Minzi; Zhang, Han; Sun, Jing; Yu, Lili; Satsangi, Jack; Larsson, Susanna C. C.; Therdoratou, Evropi; Wang, Xiaoyan; Li, Xue

英文介紹

Alimentary Pharmacology & Therapeutics雜志英文介紹

Alimentary Pharmacology & Therapeutics is an international journal of gastroenterology and hepatology.

The journal accepts original papers and systematic reviews concerned with clinical gastroenterology, hepatology and endoscopy.

AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.